NCT00871858View on ClinicalTrials.gov

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 18, 2008

Primary Completion Date

November 30, 2013

Study Completion Date

July 2, 2018

Conditions

Breast Cancer

Interventions

DRUG

anastrozole

Given orally

DRUG

fulvestrant

Given intramuscularly

Trial Locations (1)

33076

Institut Bergonie, Bordeaux

Sponsors

Lead Sponsor

Institut Bergonié

All Listed Sponsors

collaborator

National Cancer Institute, France

OTHER_GOV

lead

Institut Bergonié

OTHER